BioSpace News Archive

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a commercialization partnership with San Diego-based human identification specialist Verogen that will provide customers of both companies with superior tools and comprehensive support for human identification (HID) workflows in their laboratories.

Lexaria Bioscience Corp., a global innovator in drug delivery platforms announces the results of the 2021 Annual Meeting.

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), today announced that management will present a corporate overview at the virtual Ladenburg Thalmann Healthcare Conference

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen Inc. today announced a partnership to provide laboratories with superior tools and comprehensive support for implementing next-generation sequencing (NGS) human identification workflows.

The board of directors of Eli Lilly and Company (NYSE: LLY) (the “Board”) has declared a dividend for the third quarter of 2021 of $0.85 per share on outstanding common stock.

Fennec Pharmaceuticals Inc. announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021.

OnCusp Therapeutics (or “OnCusp”), announced that it has officially commenced operations both in New York and Shanghai.

Increased awareness about mental health disorder and improving treatment methods for the same would drive market growth.

Rising demand for innovative diagnostic techniques, neurological disorders, and increasing awareness for diseases are the major factors driving market growth.

Advancements in technology, rising use of meshes in the surgeries, and increasing geriatric population would drive market growth.